Female private care compound probiotic powder as well as preparation method and application thereof

• Main Author: ZOU SHAOXIANG
• Format: Patent
• Language: Chinese; English
• Published: 11.04.2023
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; PROCESSES USING MICROORGANISMS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES; VINEGAR; WINE

The invention discloses composite probiotic powder for female private care as well as a preparation method and application of the composite probiotic powder for female private care, and the composite probiotic powder for female private care is prepared by compounding, mixing and fermenting three bacteria of lactobacillus crispatus LC-G22, bifidobacterium infantis B1-G201 and lactobacillus gasseri LG-G12. The traditional Chinese medicine composition can kill pathogenic bacteria, regulate endocrine, repair vaginal mucosa injury and reconstruct vaginal microenvironment. Meanwhile, experimental tests accidentally find that compared with conventional composite probiotic powder obtained by compounding three kinds of bacteria including lactobacillus crispatus LC-G22, bifidobacterium infantis B1-G201 and lactobacillus gasseri LG-G12, the female private care composite probiotic powder prepared through mixed fermentation has a better treatment effect on vaginitis and urinary tract infection. In addition, the female pri